Gregory Fanning

3.1k citations

36 papers · 2.1k indexed · 1 hit paper · h-index 19

Co-authors: Antonio Bertoletti Jinlin Hou Fabien Zoulim Glen McIntyre Ken I. Welsh Maria Roussomoustakaki Édouard Louis Oliver Lenz
Topics: Hepatitis C virus research (17 papers)Hepatitis B Virus Studies (12 papers)Liver Disease Diagnosis and Treatment (8 papers)
Cited by: Hepatology Epidemiology Virology
Journals: Gastroenterology Hepatology Nature Reviews Drug Discovery
Partner nations: Belgium United States United Kingdom

In The Last Decade

Gregory Fanning

35 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic strategies for hepatitis B virus infection: towards a cure

2019 393 citations Gregory Fanning, Fabien Zoulim et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Gregory Fanning

Since Specialization

Citations

This map shows the geographic impact of Gregory Fanning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Fanning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Fanning more than expected).

Fields of papers citing papers by Gregory Fanning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Fanning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Fanning. The network helps show where Gregory Fanning may publish in the future.

Co-authorship network of co-authors of Gregory Fanning

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Fanning. A scholar is included among the top collaborators of Gregory Fanning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Fanning. Gregory Fanning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer 2020 ·Hepatology International ·Wei Chen,Ke Zhang,(unknown),Gregory Fanning,Chengcheng Tao,Haikun Zhang,Shicheng Guo,Zheng Wang,Yaqiang Hong,Xiaobo Yang,Shujuan Lai,Huiguo Ding,Haitao Zhao,Changqing Zeng,Ulrike Protzer,Dake Zhang	24
2	Author Correction: Therapeutic strategies for hepatitis B virus infection: towards a cure 2020 ·Nature Reviews Drug Discovery ·Gregory Fanning,Fabien Zoulim,Jinlin Hou,Antonio Bertoletti	8
3	Therapeutic strategies for hepatitis B virus infection: towards a curebreakdown → 2019 ·Nature Reviews Drug Discovery ·Gregory Fanning,Fabien Zoulim,Jinlin Hou,Antonio Bertoletti	393
4	TSD: A Computational Tool To Study the Complex Structural Variants Using PacBio Targeted Sequencing Data 2019 ·G3 Genes Genomes Genetics ·Guofeng Meng,Ying Tan,Yue Fan,Yan Wang,Guang Yang,Gregory Fanning,Yang Qiu	12
5	A Cellular Replicon-Based Phenotyping Assay to Determine Susceptibility of Hepatitis C Virus Clinical Isolates to NS3/4A Protease Inhibitors 2013 ·Methods in molecular biology ·Leen Vijgen,Jannick Verbeeck,(unknown),Jan Martin Berke,Diana Koletzki,Gregory Fanning,Oliver Lenz	5
6	A comparison of multiple shRNA expression methods for combinatorial RNAi 2011 ·PubMed ·Glen McIntyre,(unknown),(unknown),(unknown),Gregory Fanning	17
7	The effects of stem length and core placement on shRNA activity 2011 ·BMC Molecular Biology ·Glen McIntyre,(unknown),(unknown),Gregory Fanning	32
8	Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C virus replication complex 2010 ·Journal of Virological Methods ·Jan Martin Berke,Denis Fenistein,Frederik Pauwels,(unknown),Oliver Lenz,Tse‐I Lin,Eberhard Krausz,Gregory Fanning	8
9	Quantitation of pretreatment serum interferon-γ–inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response 2010 ·Hepatology ·Jama M. Darling,Jeroen Aerssens,Gregory Fanning,John G. McHutchison,David B. Goldstein,Alexander Thompson,Kevin V. Shianna,Nezam H. Afdhal,(unknown),Charles D. Howell,Willem Talloen,Jacques Bollekens,Mieke De Wit,Annick Scholliers,Michael Fried	88
10	Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients 2009 ·Gastroenterology ·H. W. Reesink,Gregory Fanning,(unknown),Christine J. Weegink,André van Vliet,Gerben van ‘t Klooster,Oliver Lenz,(unknown),(unknown),P. Van Remoortere,Herman de Kock,F. Broeckaert,Paul Meyvisch,(unknown),Kenneth Simmen,René Verloes	123
11	In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor 2009 ·Antimicrobial Agents and Chemotherapy ·Tse‐I Lin,Oliver Lenz,Gregory Fanning,Thierry Verbinnen,Frédéric Delouvroy,Annick Scholliers,Katrien Vermeiren,Åsa Rosenquist,Michael Edlund,Bertil Samuelsson,Lotta Vrang,Herman de Kock,Piet Wigerinck,Pierre Raboisson,Kenneth Simmen	142
12	64 SAFETY OF THE HCV PROTEASE INHIBITOR TMC435350 IN HEALTHY VOLUNTEERS AND SAFETY AND ACTIVITY IN CHRONIC HEPATITIS C INFECTED INDIVIDUALS: A PHASE I STUDY 2008 ·Journal of Hepatology ·Hendrik W. Reesink,René Verloes,(unknown),(unknown),Christine J. Weegink,Gerben van ‘t Klooster,(unknown),(unknown),P. Van Remoortere,Herman de Kock,F. Broeckaert,Gregory Fanning,Paul Meyvisch,(unknown),Kenneth Simmen	16
13	RNA as A Target for Host Defense and Anti-HIV Drugs 2006 ·Current Drug Targets ·Gregory Fanning	10
14	Gene-Expressed RNA as a Therapeutic: Issues to Consider, Using Ribozymes and Small Hairpin RNA as Specific Examples 2006 ·Handbook of experimental pharmacology ·Gregory Fanning,Geoff Symonds	4
15	Long‐term survival and concomitant gene expression of ribozyme‐transduced CD4+ T‐lymphocytes in HIV‐infected patients 2005 ·The Journal of Gene Medicine ·Janet L. Macpherson,Maureen Boyd,(unknown),Alison V. Todd,Gregory Fanning,Julie A. Ely,(unknown),(unknown),Mitch Raponi,John M. Murray,Wayne L. Gerlach,Lunquan Sun,Ronald Penny,Geoff Symonds,Andrew Carr,David A. Cooper	75
16	Polymorphic analysis of the high‐affinity tumor necrosis factor receptor 2 1999 ·Tissue Antigens ·(unknown),Penny Lympany,Patrick J. Foley,Gregory Fanning,K. I. Welsh,R M du Bois	25
17	A rapid method of haplotyping HFE mutations and linkage disequilibrium in a Caucasoid population 1998 ·Gut ·Charles G. Mullighan,M. Bunce,Gregory Fanning,Sara E. Marshall,Ken I. Welsh	31
18	HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients 1998 ·Lara D. Veeken ·Gregory Fanning,Ken I. Welsh,Christopher Bunn,Ron du Bois,C. M. Black	74
19	Genetic markers may predict disease behavior in patients with ulcerative colitis 1997 ·Gastroenterology ·Maria Roussomoustakaki,Jack Satsangi,Ken I. Welsh,Édouard Louis,Gregory Fanning,S Targan,Carol J. Landers,D P Jewell	218
20	Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin α 1997 ·Tissue Antigens ·Gregory Fanning,Michael Bunce,C. M. Black,K. I. Welsh	64

About Gregory Fanning

Gregory Fanning is a scholar working on Hepatology, Virology and Epidemiology, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (12 papers) and Liver Disease Diagnosis and Treatment (8 papers). The work is most often cited by research in Hepatology (906 citations), Epidemiology (1.1k citations) and Virology (125 citations). Gregory Fanning has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Antonio Bertoletti, Jinlin Hou, Fabien Zoulim, Glen McIntyre, Ken I. Welsh, Maria Roussomoustakaki, Édouard Louis, Oliver Lenz, Kenneth Simmen and Tse‐I Lin. Their work appears in journals such as Gastroenterology, Hepatology and Nature Reviews Drug Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact